Multiple Sclerosis: Shall We Target CD33?

Area of Science:

• Neuroscience
• Genetics
• Immunology

Background:

• Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease.
• Myeloid cells like microglia and macrophages are implicated in MS pathogenesis.
• CD33 is a myeloid cell receptor, and the rs3865444 variant's role in MS is unknown.

Purpose of the Study:

• To investigate the association between the CD33 rs3865444 variant and the risk of developing MS.

Main Methods:

• Genotyping of 1396 MS patients and 400 controls for the CD33 rs3865444 variant.
• Statistical analysis using SNPStats software under five genetic models.
• Calculation of odds ratios (ORs) and 95% confidence intervals (CIs), with p<0.05 as significance threshold.

Main Results:

• The CD33 rs3865444 variant was significantly associated with MS risk under dominant and over-dominant inheritance models.
• The GG genotype was more frequent in MS patients, while the GT genotype was less frequent, suggesting a potential risk or protective role.
• The TT genotype frequency did not differ between MS patients and controls.

Conclusions:

• Preliminary findings suggest CD33 rs3865444 may contribute to MS risk.
• Larger, multiethnic studies are recommended to further elucidate the role of CD33 rs3865444 in MS.